Hazards of anticoagulant treatment: other drugs, other diseases.
D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use; D001692:Biological Transport; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D002994:Clofibrate / Q000627:therapeutic use; D003508:Cycloheptanes / Q000627:therapeutic use; D003864:Depression, Chemical; D001728:Dicumarol / Q000032:analysis; D004221:Disulfiram / Q000627:therapeutic use; D004347:Drug Interactions; D004357:Drug Synergism; D005243:Feces / Q000032:analysis; D005260:Female; D006207:Half-Life; D006801:Humans; D007020:Hypoprothrombinemias / Q000188:drug therapy; D007231:Infant, Newborn; D010653:Phenylbutazone / Q000627:therapeutic use; D011247:Pregnancy; D011517:Prothrombin Time; D051381:Rats; D011955:Receptors, Drug; D012709:Serum Albumin / Q000378:metabolism; D014813:Vitamin K Deficiency / Q000150:complications; D014859:Warfarin / Q000097:blood
D000925:Anticoagulants; D001463:Barbiturates; D001779:Blood Coagulation Factors; D003508:Cycloheptanes; D011955:Receptors, Drug; D012709:Serum Albumin; D014859:Warfarin; D001728:Dicumarol; D010653:Phenylbutazone; D002994:Clofibrate; D004221:Disulfiram